Top News

Astra Zeneca will utilize the Proteome-SEQ service from Biognosys

SBA Member News, 21.11.2014

Biognosys AG, a Swiss Proteomics Company, announced today a collaboration project with Astra Zeneca where it will utilize the recently launched Proteome-SEQ service. This is another addition to a growing list of leading pharmaceutical companies using the next-generation proteomics technology of Biognosys.


Neuer ESAO-Präsident ernannt

transkript, 20.11.2014

Next Event


Community Login

Bachem Holding AG

 Wissenschaft im Gespraech | Den Naturwissenschaften fehlt der Nachwuchs | Schweizer Radio DRS

The potential in the land

LRC TriCEPS™ technology

BBC - End of Drug Discovery